You may be right, but this assumes that GSK is totally unconcerned about the affect that stroppy delay would have on other prospective junior drug partners.
They are bleeding Vitamin C free Ribena this week, shown up as falsifiers by a New Zealand school girl.
Suppose you have a new wonder drug. Would you go to GSK or try somebody else?